Ganoderma lucidum, or Ganoderma lucidum peptide injection, has the ability to treat progressive muscular dystrophy and other diseases, with side effects such as fever and rash, and is contraindicated in allergic individuals.
The main ingredient of Ganoderma lucidum injection is sterilized aqueous solution extracted from dried mycelium powder of Ganoderma lucidum.
Ganoderma lucidum injection is effective in the treatment of progressive muscular dystrophy, atrophic myasthenia gravis, vestibular dysfunction, dizziness and autonomic dysfunction caused by hypertension, epilepsy, insomnia, etc. In addition, Ganoderma lucidum injection is also effective in the treatment of dizziness and autonomic dysfunction caused by atrophic myasthenia gravis. In addition, Bozhi Glycopeptide Injection can also be used for the adjuvant treatment of tumor and hepatitis.
Some patients may experience side effects such as fever and rash after using Thin Glucoside Injection. It should be noted that it is forbidden for patients who are allergic to Bozhidu Glycopeptide Injection to prevent allergic symptoms such as generalized itching, respiratory distress and shock.
Patients should consult a doctor before using Thin Glucoside Injection and follow the doctor’s instructions to avoid blind use of medication.